Sustained-release topiramate formulations
AssigneeCadila Healthcare Limited
InventorsSUSHRUT KRISHNAJI KULKARNI, AJAYKUMAR HANDA, AMIT OM PRAKASH GUPTA, PRUDHVI RAJU DANTULURI
Life of this patent
Estimating the term…
Abstract
The present invention relates to a sustained release pharmaceutical formulation comprising topiramate and one or more pharmaceutically acceptable excipients, wherein the formulation comprises two extended release (XR) components or a combination of an extended release (XR) component and immediate release (IR) component, wherein at least one component is in a matrix form. It also relates to method of preparing such formulations and using those formulations in the treatment of neurological and/or psychiatric condition.
Claims21
A sustained release formulation of topiramate comprising two extended release components, a first extended release component (XR1) and a second extended release component (XR2), wherein topiramate is present in both the components and at least one of the components is present in a matrix form.
A sustained release formulation of topiramate comprising an immediate release component (IR) and an extended release component (XR), wherein topiramate is present in both the components and at least one of the components is in a matrix form.
Dependencies are inferred from the claim text.